Literature DB >> 74226

Bleomycin hypersensitivity pneumonitis.

P Y Holoye, M A Luna, B MacKay, C W Bedrossian.   

Abstract

Three patients developed radiologic and functional pulmonary changes after bleomycin therapy similar to ones previously associated with administration of this drug. However, biopsy specimens showed a pattern consistent with hypersensitivity pneumonitis rather than the interstitial pneumonia usually reported in bleomycin pulmonary toxicity. There was a patchy eosinophilic infiltrate surrounding small airways and distal air spaces, but no immune deposits were noted by ultrastructure or immunofluorescence using conventional techniques and a specific antibody against bleomycin. Two of the patients had peripheral eosinophilia of 12% and 16%. All three patients showed considerable improvement on chest roentgenogram after corticosteroid treatment. Our findings are consistant with the view that bleomycin hypersensitivity pneumonitis has a different pathogenesis than bleomycin interstitial pneumonitis. Its recognition as a separate entity seems warrnated because of the favorable response to steroid therapy.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 74226     DOI: 10.7326/0003-4819-88-1-47

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  14 in total

1.  Severe bleomycin lung toxicity: reversal with high dose corticosteroids.

Authors:  J Maher; P A Daly
Journal:  Thorax       Date:  1993-01       Impact factor: 9.139

Review 2.  The Therapeutic Potential of Mesenchymal Stromal Cells in the Treatment of Chemotherapy-Induced Tissue Damage.

Authors:  Alexander Rühle; Ramon Lopez Perez; Bingwen Zou; Anca-Ligia Grosu; Peter E Huber; Nils H Nicolay
Journal:  Stem Cell Rev Rep       Date:  2019-06       Impact factor: 5.739

Review 3.  Lung damage from cytotoxic drugs.

Authors:  C H Collis
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

4.  Bleomycin-induced lung injury in baboons: alteration of cells and immunoglobulins recoverable by bronchoalveolar lavage.

Authors:  B McCullough; S Schneider; N D Greene; W G Johanson
Journal:  Lung       Date:  1978       Impact factor: 2.584

5.  Cell-mediated immunity against connective tissue in experimental pulmonary fibrosis.

Authors:  R E Carvajal; R González; F Vargas-A; M Selman
Journal:  Lung       Date:  1982       Impact factor: 2.584

Review 6.  Mechanisms of bleomycin-induced lung damage.

Authors:  J Hay; S Shahzeidi; G Laurent
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

Review 7.  Drug-induced respiratory disorders: incidence, prevention and management.

Authors:  L Ben-Noun
Journal:  Drug Saf       Date:  2000-08       Impact factor: 5.606

8.  Eosinophilic pneumonia associated with bleomycin in a patient with mediastinal seminoma: a case report.

Authors:  Sanjaykumar Hapani; David Chu; Shenhong Wu
Journal:  J Med Case Rep       Date:  2010-04-29

9.  Bleomycin-induced pulmonary fibrosis in the rat: inhibition by indomethacin.

Authors:  R S Thrall; J R McCormick; R M Jack; R A McReynolds; P A Ward
Journal:  Am J Pathol       Date:  1979-04       Impact factor: 4.307

10.  [Bleomycin-induced pulmonary infiltrations in the treatment of testicular cancer].

Authors:  C Clemm; R Hartenstein; B Mayr; W Wilmanns
Journal:  Klin Wochenschr       Date:  1984-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.